rs34928889

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000455.5(STK11):​c.375-49G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.451 in 1,548,922 control chromosomes in the GnomAD database, including 162,185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.46 ( 16494 hom., cov: 34)
Exomes 𝑓: 0.45 ( 145691 hom. )

Consequence

STK11
NM_000455.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:5

Conservation

PhyloP100: -0.814

Publications

12 publications found
Variant links:
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
STK11 Gene-Disease associations (from GenCC):
  • familial pancreatic carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Peutz-Jeghers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-1219275-G-A is Benign according to our data. Variant chr19-1219275-G-A is described in ClinVar as [Benign]. Clinvar id is 256205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK11NM_000455.5 linkc.375-49G>A intron_variant Intron 2 of 9 ENST00000326873.12 NP_000446.1 Q15831-1A0A0S2Z4D1
STK11NM_001407255.1 linkc.375-49G>A intron_variant Intron 2 of 8 NP_001394184.1
STK11NR_176325.1 linkn.1642-49G>A intron_variant Intron 3 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK11ENST00000326873.12 linkc.375-49G>A intron_variant Intron 2 of 9 1 NM_000455.5 ENSP00000324856.6 Q15831-1
STK11ENST00000652231.1 linkc.375-49G>A intron_variant Intron 2 of 8 ENSP00000498804.1 Q15831-2
STK11ENST00000585748.3 linkc.3-49G>A intron_variant Intron 4 of 11 3 ENSP00000477641.2 A0A087WT72
STK11ENST00000593219.6 linkn.*200-49G>A intron_variant Intron 3 of 10 3 ENSP00000466610.1 K7EMR0

Frequencies

GnomAD3 genomes
AF:
0.457
AC:
69479
AN:
151980
Hom.:
16466
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.471
Gnomad AMI
AF:
0.366
Gnomad AMR
AF:
0.434
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.846
Gnomad SAS
AF:
0.482
Gnomad FIN
AF:
0.456
Gnomad MID
AF:
0.443
Gnomad NFE
AF:
0.426
Gnomad OTH
AF:
0.446
GnomAD2 exomes
AF:
0.468
AC:
73682
AN:
157324
AF XY:
0.469
show subpopulations
Gnomad AFR exome
AF:
0.474
Gnomad AMR exome
AF:
0.411
Gnomad ASJ exome
AF:
0.410
Gnomad EAS exome
AF:
0.855
Gnomad FIN exome
AF:
0.467
Gnomad NFE exome
AF:
0.429
Gnomad OTH exome
AF:
0.452
GnomAD4 exome
AF:
0.451
AC:
629562
AN:
1396824
Hom.:
145691
Cov.:
30
AF XY:
0.451
AC XY:
310503
AN XY:
689184
show subpopulations
African (AFR)
AF:
0.468
AC:
14805
AN:
31668
American (AMR)
AF:
0.414
AC:
14870
AN:
35900
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
10417
AN:
25138
East Asian (EAS)
AF:
0.859
AC:
30842
AN:
35908
South Asian (SAS)
AF:
0.471
AC:
37329
AN:
79298
European-Finnish (FIN)
AF:
0.466
AC:
22470
AN:
48264
Middle Eastern (MID)
AF:
0.448
AC:
2548
AN:
5688
European-Non Finnish (NFE)
AF:
0.436
AC:
469487
AN:
1077012
Other (OTH)
AF:
0.462
AC:
26794
AN:
57948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17724
35447
53171
70894
88618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14660
29320
43980
58640
73300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.457
AC:
69563
AN:
152098
Hom.:
16494
Cov.:
34
AF XY:
0.463
AC XY:
34395
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.472
AC:
19580
AN:
41510
American (AMR)
AF:
0.434
AC:
6645
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1443
AN:
3472
East Asian (EAS)
AF:
0.846
AC:
4357
AN:
5150
South Asian (SAS)
AF:
0.483
AC:
2327
AN:
4820
European-Finnish (FIN)
AF:
0.456
AC:
4831
AN:
10584
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.426
AC:
28956
AN:
67950
Other (OTH)
AF:
0.452
AC:
956
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1919
3838
5757
7676
9595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.426
Hom.:
2992
Bravo
AF:
0.457
Asia WGS
AF:
0.661
AC:
2297
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Squamous cell lung carcinoma Uncertain:1
May 05, 2020
Faculté Pluridciplinaire Nador, Université Mohamed Premier
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing;in vivo

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Nov 18, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Peutz-Jeghers syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.1
DANN
Benign
0.63
PhyloP100
-0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34928889; hg19: chr19-1219274; API